Steve Schonfeld’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$138K Buy
+10,244
New +$128K ﹤0.01% 2444
2026
Q1
– Sell
-14,349
Closed -$117K – 2548
2025
Q4
$117K Buy
+14,349
New +$165K ﹤0.01% 1795
2025
Q2
– Sell
-426,902
Closed -$2.38M – 2406
2025
Q1
$2.38M Sell
426,902
-297,417
-41% -$2.6M 0.01% 876
2024
Q4
$5.85M Buy
+724,319
New +$6.65M 0.03% 454
2022
Q4
– Sell
-11,800
Closed -$38K – 2894
2022
Q3
$38K Sell
11,800
-18,000
-60% -$72.1K ﹤0.01% 2669
2022
Q2
$133K Buy
29,800
+2,200
+8% +$8.78K ﹤0.01% 2060
2022
Q1
$148K Buy
+27,600
New +$249K ﹤0.01% 2105

Other funds holding ORIC

Steve Schonfeld's ORIC Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Oric Pharmaceuticals (ORIC) in Q3 2026: 10,244 shares worth $138K. The stake represents ﹤0.01% of the portfolio and ranks #2444 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in ORIC as recently as Q4 2025.

Steve Schonfeld first reported a position in ORIC in Q1 2022 and has held it in 7 quarters since. The position peaked at $5.85M in Q4 2024. 191 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Steve Schonfeld held 10,244 shares of Oric Pharmaceuticals worth $138K as of Q3 2026.
  • Oric Pharmaceuticals was a new Steve Schonfeld position in Q3 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2444 holding.
  • Steve Schonfeld first reported a position in Oric Pharmaceuticals in Q1 2022 and has held it in 7 quarters since.
  • Steve Schonfeld's Oric Pharmaceuticals position peaked at $5.85M in Q4 2024.
  • 191 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.